Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Is Clover Health Finally Turning the Corner?
07:30am, Monday, 03'rd Aug 2026
Clover Health (NASDAQ:CLOV) has spent years as a speculative bet on a technology-led Medicare Advantage model.
Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
08:21am, Friday, 31'st Jul 2026
The disposition involved 62,711 shares at a weighted average price of $4.67 per share, totaling ~$292,860 in transaction value. The transaction represented 0.65% of the executive's direct equity holdi
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
04:05pm, Wednesday, 22'nd Jul 2026
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Fin
Clover Health says employee accounts accessed in cyber incident
04:49pm, Friday, 17'th Jul 2026
Clover Health Investments said in a regulatory filing on Friday that it detected unusual login activity on some of its information systems on July 4 and later found a hacker had gained access to
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
04:05pm, Thursday, 09'th Jul 2026
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its f
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or “Clov
Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.
08:32pm, Monday, 06'th Jul 2026
CEO Andrew Toy sold 313,476 shares of Common Stock for a transaction value of ~$1.67 million as of July 1, 2026. This transaction represented 3.16% of Toy's direct holdings, reducing direct ownership
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.
01:13pm, Saturday, 27'th Jun 2026
Director Carladenise Edwards sold 67,160 shares for a transaction value of approximately ~$230,000 on May 18, 2026, at a weighted average price of around $3.42 per share. This sale represented 19% of
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating
07:32am, Thursday, 11'th Jun 2026
Clover Health Investments Corp. (NASDAQ:CLOV) shares are extending yesterday's 18.9% surge Thursday, after a court-ordered Medicare Star Rating upgrade jumped its PPO plan from 3.5 to 4.5 Stars.
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors?
02:04pm, Friday, 05'th Jun 2026
This healthcare technology company focused on Medicare Advantage plans saw a notable insider sale following a year of strong stock gains.
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
01:11pm, Thursday, 07'th May 2026
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises
12:51pm, Thursday, 07'th May 2026
CLOV posts 62% revenue growth in Q1 as Medicare Advantage membership surges and AI-driven care initiatives boost profitability.
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
07:35pm, Wednesday, 06'th May 2026
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.07 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.05 per share a year ago.
Clover Health Reports First Quarter 2026 Results
04:05pm, Wednesday, 06'th May 2026
Business Highlights: Delivered positive GAAP Net Income in the first quarter of 2026, with strong performance across key metrics: Total revenues, Adjusted EBITDA, and Consolidated Gross Profit Market-
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Beats Revenue Estimates
08:41am, Thursday, 30'th Apr 2026
Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.06 per share a year ago.
